
Although not surprising, still a disappointing print from $Aehr Test(AEHR.US) last night in their Q4 FY25 report; with additional read-across information for the global #SiC market.
FY25 Results - Revenue: USD 59m vs. Jan. Guidance USD 70m+ - Profit before taxes: USD -4.3m loss vs. Jan. Guidance USD 7m+***Yes, the company already pulled guidance in Q3 (April) due to "ongoing tariff uncertainty", but this still gives a sense of how dramatically things unraveled.Source: Chips & Wafers
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
